{"name":"Active Biotech AB","slug":"active-biotech-ab","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ABR-217620","genericName":"ABR-217620","slug":"abr-217620","indication":"Other","status":"phase_1"},{"name":"ABR-215050","genericName":"ABR-215050","slug":"abr-215050","indication":"Other","status":"phase_1"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"ABR-215050, tasquinimod","genericName":"ABR-215050, tasquinimod","slug":"abr-215050-tasquinimod","indication":"Prostate cancer","status":"phase_2"},{"name":"IFN-alpha","genericName":"IFN-alpha","slug":"ifn-alpha","indication":"Hairy cell leukemia","status":"phase_2"}]}],"pipeline":[{"name":"ABR-217620","genericName":"ABR-217620","slug":"abr-217620","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ABR-215050","genericName":"ABR-215050","slug":"abr-215050","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ABR-215050, tasquinimod","genericName":"ABR-215050, tasquinimod","slug":"abr-215050-tasquinimod","phase":"phase_2","mechanism":"Tasquinimod is a quinoline-3-carboxamide derivative that modulates the immune system by targeting the S100A9 protein.","indications":["Prostate cancer"],"catalyst":""},{"name":"IFN-alpha","genericName":"IFN-alpha","slug":"ifn-alpha","phase":"phase_2","mechanism":"Interferes with viral replication by binding to the cell surface receptor for the virus.","indications":["Hairy cell leukemia","Chronic myelogenous leukemia","Multiple sclerosis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPeDFCczl5UXY0YTNvRnNtMUJPaHMtb0Q2VHpEVFV0QU9OWUxUMDdDT1pNZXAwTmVWOHdvbUNGU0U5d1FxZF94bk1qeVNVRzE0dC1qd3BkRkhmQUR5SUdieXM0czZFaWljZ2ZOMjJxMzJDa2tYQ19iWmxLaTVkSzJOUzY3aHczaG91VVg0OTg2TUpWekNuY2VTY1BTOERfMVRHSjliVHR3eVNWbDlEcXViblVOODJsSVBYdHc?oc=5","date":"2026-04-08","type":"pipeline","source":"TradingView","summary":"AlzeCure Pharma publishes its Annual Report for 2025 - TradingView","headline":"AlzeCure Pharma publishes its Annual Report for 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTFAxV1VHb1hxdHIxSkx3VnpqWE5IS051TkNoNlRTcENaVnRxbWJid0w0empfWkRuNkoxRkE0ZmthY184em1RZnJFSVNUZmFBY2pkOHdoZFJn?oc=5","date":"2026-04-02","type":"pipeline","source":"Yahoo Finance UK","summary":"Active Biotech AB (publ) (ACTI.ST) stock price, news, quote and history - Yahoo Finance UK","headline":"Active Biotech AB (publ) (ACTI.ST) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPeVN6S0tOd29HcS04WFBTZGk4azBSN3E5OC1Qa3V5VUo3emk2S0J5ZWt0YmtLZkdyQUpHNnVNaVZ1VnNKTHUtUHdYVFF5ckJZQ3F2bGdQb21CSVNXekdrTlY1bUhrR2NKVHYzcWFaZlAxcm1xUEMyWDcxYUI5dzExVmloa0dnUk9qd2Y4bUstQkhiOHBzSFpscUNna3BXV0NzOWRvV24wOHF1T0ZURTlId1pocWh2cHdsR0Nv?oc=5","date":"2026-02-17","type":"pipeline","source":"AD HOC NEWS","summary":"Pieris Pharmaceuticals: What a Delisting Biotech Still Signals for Risk?Hungry Traders - AD HOC NEWS","headline":"Pieris Pharmaceuticals: What a Delisting Biotech Still Signals for Risk?Hungry Traders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxQUWRERElXWDNJa2YzOENEQ2RDMl9lWUotOVZudHFjQXM5VUdYZ0ptNWEweHQzeVFrdF9OVTJXZ05qNGY0R0REZlYyQW96c2ZreVVrempuMzd1Mm42ZC1xMVkxdzRoUVNVeHdVSkVnaGdyWUxUdERoV3BpeTc0UEVRMlBlTFRJRjRmTm5RNGx3cjNzRXBmSlpKazFabE5fNUI2WlZ1M2JTb3NHakZFd2IzZktEN0lSWkdJbnJQd0UzaGV4MTFqUzdQN3Ffc2R6dXVuM3hUUVRCN2d1X2tDSDRkSFhnVTVwZw?oc=5","date":"2025-11-18","type":"deal","source":"Cision News","summary":"TIRmed Enters into Collaboration with Bachem to Advance Oligonucleotide Therapy for Atopic Dermatitis - Cision News","headline":"TIRmed Enters into Collaboration with Bachem to Advance Oligonucleotide Therapy for Atopic Dermatitis","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-28","type":"earnings","source":"simplywall.st","summary":"We Might See A Profit From Active Biotech AB (publ) (STO:ACTI) Soon - simplywall.st","headline":"We Might See A Profit From Active Biotech AB (publ) (STO:ACTI) Soon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxNcDB0c1ZnNERIQ1BMU3MzMzZCWkxMNGszUFBqaEQzcWV6OWhNWnhEODc0ZFVxcl80NmVyLVFSMWlFQ1BqUmxicHpsMVJjZ2E0OUhVTlBhMDBXQVpnb1EyNkdUeklvYTNaNzdWT255Y2tSc3NCclZZX3Vib1FORVR5eGpBMk5RWUd1QlpMWk9MZ1U3Y202WVZOODFHbGhSOXpIQUVRQjlkUkFTaF9Ucl9HWDhOZTVSeW5jYmd6b2xfRFZKN3owUDc0bDFUNFMtbXFnQ0hWNVVOVVVWV2xrRjhfeEhmdFV5Wk82Q0M5X3lHWk9Bejl1dnhTTnl2S1FSZXo2Q09oR2FZTHQ?oc=5","date":"2025-06-11","type":"deal","source":"PR Newswire","summary":"Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutics - PR Newswire","headline":"Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQR1czbDg2WjEwbF9JcHdLWmFFbk5yTERERUY0TFo5T2tCM3BSa1NNYkliYWt6a1FORmt1U1IzVDJYZkR2SHY0el95bU51X1NBaWItVl9yMUxMN0hHWGxIeEFuTTRiTEs3VVNzcTFNUXFtWV9OWG82NEFQR0l1cGFkYTZpWUNJNFNIV09lR1lnVjNwbWlZOGp1NDJOcTlkUTdqazIxM3N3?oc=5","date":"2024-06-27","type":"pipeline","source":"BioSpace","summary":"Active Pharmaceutical Ingredient CDMO Market Size to Hit USD 249.22 Bn by 2033 - BioSpace","headline":"Active Pharmaceutical Ingredient CDMO Market Size to Hit USD 249.22 Bn by 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxONjI2THYyOU9rbVhMMDRXU1JWNF9zcjRaT0R2TXR3SU5iQTktN1FYTlY1YzQzSkstRVFGZGxsOWg1RThVWENZTkRmemYyMEhBZzZFWUJZZ2h1YVJzN1NKaVpBSmMzWEU0TXlUbVhaZ0JtLTZDZmxiM1JEU1dBcU1PMg?oc=5","date":"2024-01-04","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '24: AusperBio adds $73M series B; Ottimo raises $140M - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '24: AusperBio adds $73M series B; Ottimo raises $140M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPbTEzZjh3VUZ4eDZTelRDVXlNRmNmS3Mzd1JxcnJ2bEVEcGdRLTVsU3cxSjVfc21DSDhtZVkzdDl3TVROSTRLM0g1Z0dwNU14T1cwd3hGMjYzSmtmQ2pFVVNzcERFRjdTb3lPVEY3dmpod3I4U0ozMnVtLVRaRE12VTlUaHhPelAydU83ejVSRmRvTWk4NlppMlh1UzhCTUFRYkJtcmd6QU5odFk3OURpTUZ3?oc=5","date":"2022-05-18","type":"pipeline","source":"Medical Professionals Reference","summary":"Tasquinimod Gets Orphan Drug Designation for Myelofibrosis - Medical Professionals Reference","headline":"Tasquinimod Gets Orphan Drug Designation for Myelofibrosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFBYVlpOWU1RVWFhYjFrRlhZTG9kd3A2RG1fVk5IMkpsUGI4QnNqMnE5U0hHZFg3aVVrdDNidXlfWjlmS3U5Rk12VzdFZVo0QWVPVjUwcjFBeUZ5Nmc0?oc=5","date":"2018-04-13","type":"pipeline","source":"TradingView","summary":"ACTI Stock Price and Chart — OMXSTO:ACTI - TradingView","headline":"ACTI Stock Price and Chart — OMXSTO:ACTI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNUm1sMlRQWnItWldMQl9aSDd3U1AwZ0pTcm9rZVFyM2xjZ0drWHFMS25zNDRZbWVOZERJU05HeXVSa3FVdDlNYndHRkhQZmxScE0xSnY5djZZZ0ozNC1tYzRwYmtRT0NEbDJZMjRVcGtWRUsxenJfWENvc05FS2wwSHdaY2NXZ0d3c2paZ3Z3?oc=5","date":"2014-05-07","type":"pipeline","source":"Contract Pharma","summary":"Novavax Names Corporate Development SVP - Contract Pharma","headline":"Novavax Names Corporate Development SVP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPYm42NlBJa3hrUXpSVVRDdGVGU2NTTnA3Rzg3UGk0dGIwaGNDQmZRRjdMMEZTdUw3ZzAwTDNRa0NyN3Y5aEcyRVhYS1hjQ1RJSHRwY1F2MjBSZDI5TjFSb0VnMzNDTENEaTBhQUdjdWZ6VkYtN1FZTzB6Ti1xcm1yRm1oNVhLV04wN3hucUotcXU0VklCa0hLVnhtRVZFb1VrQktPRENBUGJ6eU9zcExXcjg5NWNKM0dzMzQxZkFtYw?oc=5","date":"2011-10-19","type":"pipeline","source":"Fierce Pharma","summary":"Investigational Laquinimod Demonstrates Its Potential as a New Oral Treatment For RRMS - Fierce Pharma","headline":"Investigational Laquinimod Demonstrates Its Potential as a New Oral Treatment For RRMS","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_1":2,"phase_2":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}